ArticleBMC neurology2023

Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.

Juliane Klehmet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.